PSMB8-AS1

From LncRNAWiki
Revision as of 06:44, 28 January 2021 by Chang Liu (talk | contribs) (Created page with "The aberrant expression of PSMB8-AS1 is highly relevant to glioma tumorigenesis and prognosis of GBM patients.<ref name="ref1" /> ==Annotated Information== ===Name===...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

The aberrant expression of PSMB8-AS1 is highly relevant to glioma tumorigenesis and prognosis of GBM patients.[1]

Annotated Information

Name

Approved symbol:PSMB8-AS1

Approved name:PSMB8 antisense RNA 1 (head to head)

HGNC ID HGNC:39758

Previous name:TAP1 and PSMB8 antisense RNA 1

Alias symbol:XXbac-BPG246D15.8|TAP1-AS1

RefSeq ID:NR_037173

LncBook ID:HSALNG0049455

Prev_symbol:TAPSAR1

Characteristics

PSMB8-AS1 mainly located in cytoplasm of glioblastoma cells, indicating post-transcriptional regulation.[1]

Function

PSMB8-AS1 regulating GBM cell proliferation, apoptosis and radioresistance . overexpression of PSMB8-AS1 promoted the level of DDIT4 through inhibiting miR-22-3p.[1]

Regulation

LncRNA PSMB8-AS1 acts as miR-22-3p sponge to mediate DDIT4 expression and regulate glioblastoma progression.[1]

Expression

High expression trends of lncRNA PSMB8-AS1 was observed in both glioblastoma tissues and cells. [1]

Diseases

Glioblastoma (GBM)[1]

Labs working on this lncRNA

  • Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, 030012, China.[1]
  • Department of Neurosurgery, Heze Municipal Hospital, Heze, Shandong, 274033, China.[1]
  • Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272029, China. Electronic address: hanguangkui1997@163.com.[1]

References

[1](1)

</references>
  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Hu T, Wang F, Han G. LncRNA PSMB8-AS1 acts as ceRNA of miR-22-3p to regulate DDIT4 expression in glioblastoma. Neurosci Lett. 2020 May 29;728:134896. doi: 10.1016/j.neulet.2020.134896. Epub 2020 Mar 6.